Author: Minichart

Hong Kong Corporate News

Abbisko Therapeutics Begins Phase I/II Clinical Trial of Oral KRAS G12D Inhibitor ABSK141 for Advanced Solid Tumors 12

Minichart

March 4, 2026

Abbisko Therapeutics Announces First Patient Dosing in KRAS ...

Continue Reading 0

Hong Kong Corporate News

ASMPT Limited Reports Strong 2025 Annual Results Driven by AI Growth and Advanced Packaging Leadership

Minichart

March 4, 2026

ASMPT Limited 2025 Annual Results: Investor-Focused Detailed...

Continue Reading 0

Hong Kong Corporate News

ASMPT Limited 2025 Audited Financial Results: AI-Driven Growth, Dividends, Segment Performance, and Strategic Initiatives

Minichart

March 4, 2026

ASMPT Limited Announces Robust FY2025 Results: AI-Driven Gro...

Continue Reading 0

Hong Kong Corporate News

Sino Biopharmaceutical and Sanofi Sign Global Exclusive License Agreement for ROVADICITINIB, a First-in-Class JAK/ROCK Inhibitor 12

Minichart

March 4, 2026

Sino Biopharm Signs Major Global License Deal with Sanofi fo...

Continue Reading 0

us corporate news

Agilent Technologies, Inc. Q1 2026 Quarterly Financial Report – Revenue, Earnings, and SEC Filings Highlights

Minichart

March 4, 2026

Summary of Financial Results Quarter Ended: January 31, 2...

Continue Reading 0

us corporate news

ABVC BioPharma, Inc. 10-Q/A Restated Financials for Q3 2025 – SEC Filing, Financial Statements & Analysis

Minichart

March 4, 2026

ABVC BioPharma, Inc. Files Restated Quarterly Report: Key Hi...

Continue Reading 0

us corporate news

Copart, Inc. Q2 2026 Quarterly Report on Form 10-Q – Financial Statements, Management Analysis, and Disclosures

Minichart

March 4, 2026

Copart, Inc. Q2 2026 Financial Results: In-Depth Investor An...

Continue Reading 0

us corporate news

Credo Technology Group Holding Ltd 10-Q Report January 2026: Financial Highlights, Balance Sheet, and Forward-Looking Statements

Minichart

March 4, 2026

Credo Technology Group Holding Ltd: Key Highlights from Q3 F...

Continue Reading 0

us corporate news

Amended and Restated Sales Agreement of Canton Strategic Holdings, Inc. with Clear Street LLC and Virtu Americas LLC (2026)

Minichart

March 4, 2026

Canton Strategic Holdings, Inc. - Key Developments in Form 8...

Continue Reading 0

us corporate news

Rigel Pharmaceuticals Reports Record 2025 Financial Results, Advances Clinical Programs, and Issues Positive 2026 Outlook

Minichart

March 4, 2026

Rigel Pharmaceuticals Reports Record 2025 Results, Issues Bu...

Continue Reading 0